Reproductive factors and breast cancer risk among BRCA1 or BRCA2 mutation carriers: Results from ten studies

Cancer Epidemiology

Volumn 38, Issue 1, 2014, Pages 1-8

  Pan, Hong ^a   He, Zhongyuan ^b   Ling, Lijun ^a   Ding, Qiang ^a   Chen, Lin ^a   Zha, Xiaoming ^a   Zhou, Wenbin ^a   Liu, Xiaoan ^a   Wang, Shui ^a  

^a THE FIRST AFFILIATED HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

^b THE FIRST AFFILIATED HOSPITAL OF SOOCHOW UNIVERSITY   (China)

Author keywords

Age at first birth; BRCA1 or BRCA2; Breast cancer; Breastfeeding; Menarche; Parity

Indexed keywords

AGE AT FIRST BIRTH; BRCA1 OR BRCA2; BREAST CANCER; BREASTFEEDING; MENARCHE; PARITY;

AGE FACTORS; BREAST FEEDING; BREAST NEOPLASMS; FEMALE; GENES, BRCA1; GENES, BRCA2; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MUTATION; REPRODUCTIVE HISTORY; RISK FACTORS;

EID: 84894284432     PISSN: 18777821     EISSN: 1877783X     Source Type: Journal    
DOI: 10.1016/j.canep.2013.11.004     Document Type: Review

References (41)

1. Ford D., Easton D.F., Bishop D.T., Narod S.A., Goldgar D.E. Risks of cancer in BRCA1-mutation carriers. Breast Cancer Linkage Consortium. Lancet 1994, 343(8899):692-695.
2. Mavaddat N., Peock S., Frost D., Ellis S., Platte R., Fineberg E., et al. Cancer risks for BRCA1 and BRCA2 mutation carriers: results from prospective analysis of EMBRACE. J Natl Cancer Inst 2013, 105(11):812-822.
3. Antoniou A., Pharoah P.D., Narod S., Risch H.A., Eyfjord J.E., Hopper J.L., et al. Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies. Am J Hum Genet 2003, 72(5):1117-1130.
4. Smith A., Moran A., Boyd M.C., Bulman M., Shenton A., Smith L., et al. Phenocopies in BRCA1 and BRCA2 families: evidence for modifier genes and implications for screening. J Med Genet 2007, 44(1):10-15.
5. Goldgar D., Venne V., Conner T., Buys S. BRCA phenocopies or ascertainment bias?. J Med Genet 2007, 44(8):e86. [author reply e88].
6. King M.C., Marks J.H., Mandell J.B. Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2. Science 2003, 302(5645):643-646.
7. Breast cancer and breastfeeding: collaborative reanalysis of individual data from 47 epidemiological studies in 30 countries, including 50302 women with breast cancer and 96973 women without the disease. Lancet 2002, 360(9328):187-195.
8. Reeves G.K., Pirie K., Green J., Bull D., Beral V. Reproductive factors and specific histological types of breast cancer: prospective study and meta-analysis. Br J Cancer 2009, 100(3):538-544.
9. Kelsey J.L., Gammon M.D., John E.M. Reproductive factors and breast cancer. Epidemiol Rev 1993, 15(1):36-47.
10. Key T.J., Verkasalo P.K., Banks E. Epidemiology of breast cancer. Lancet Oncol 2001, 2(3):133-140.
11. Cullinane C.A., Lubinski J., Neuhausen S.L., Ghadirian P., Lynch H.T., Isaacs C., et al. Effect of pregnancy as a risk factor for breast cancer in BRCA1/BRCA2 mutation carriers. Int J Cancer 2005, 117(6):988-991.
12. Jernstrom H., Lerman C., Ghadirian P., Lynch H.T., Weber B., Garber J., et al. Pregnancy and risk of early breast cancer in carriers of BRCA1 and BRCA2. Lancet 1999, 354(9193):1846-1850.
13. Gronwald J., Byrski T., Huzarski T., Cybulski C., Sun P., Tulman A., et al. Influence of selected lifestyle factors on breast and ovarian cancer risk in BRCA1 mutation carriers from Poland. Breast Cancer Res Treat 2006, 95(2):105-109.
14. Andrieu N., Goldgar D.E., Easton D.F., Rookus M., Brohet R., Antoniou A.C., et al. Pregnancies, breast-feeding, and breast cancer risk in the International BRCA1/2 Carrier Cohort Study (IBCCS). J Natl Cancer Inst 2006, 98(8):535-544.
15. Antoniou A.C., Shenton A., Maher E.R., Watson E., Woodward E., Lalloo F., et al. Parity and breast cancer risk among BRCA1 and BRCA2 mutation carriers. Breast Cancer Res 2006, 8(6):R72.
16. Kotsopoulos J., Lubinski J., Salmena L., Lynch H.T., Kim-Sing C., Foulkes W.D., et al. Breastfeeding and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers. Breast Cancer Res 2012, 14(2):R42.
17. Kotsopoulos J., Lubinski J., Lynch H.T., Neuhausen S.L., Ghadirian P., Isaacs C., et al. Age at menarche and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers. Cancer Causes Control 2005, 16(6):667-674.
18. Jernstrom H., Lubinski J., Lynch H.T., Ghadirian P., Neuhausen S., Isaacs C., et al. Breast-feeding and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers. J Natl Cancer Inst 2004, 96(14):1094-1098.
19. Lau J., Ioannidis J.P., Schmid C.H. Quantitative synthesis in systematic reviews. Ann Intern Med 1997, 127(9):820-826.
20. Mantel N., Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 1959, 22(4):719-748.
21. DerSimonian R., Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986, 7(3):177-188.
22. Begg C.B., Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics 1994, 50(4):1088-1101.
23. Egger M., Davey Smith G., Schneider M., Minder C. Bias in meta-analysis detected by a simple, graphical test. Br Med J 1997, 315(7109):629-634.
24. Kotsopoulos J., Lubinski J., Lynch H.T., Klijn J., Ghadirian P., Neuhausen S.L., et al. Age at first birth and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers. Breast Cancer Res Treat 2007, 105(2):221-228.
25. Milne R.L., Osorio A., Ramon, Cajal T., Baiget M., Lasa A., Diaz-Rubio E., et al. Parity and the risk of breast and ovarian cancer in BRCA1 and BRCA2 mutation carriers. Breast Cancer Res Treat 2010, 119(1):221-232.
26. Rebbeck T.R., Wang Y., Kantoff P.W., Krithivas K., Neuhausen S.L., Godwin A.K., et al. Modification of BRCA1- and BRCA2-associated breast cancer risk by AIB1 genotype and reproductive history. Cancer Res 2001, 61(14):5420-5424.
27. Kotsopoulos J., Lubinski J., Lynch H.T., Kim-Sing C., Neuhausen S., Demsky R., et al. Oophorectomy after menopause and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers. Cancer Epidemiol Biomarkers Prev 2012, 21(7):1089-1096.
28. Chang-Claude J., Andrieu N., Rookus M., Brohet R., Antoniou A.C., Peock S., et al. Age at menarche and menopause and breast cancer risk in the International BRCA1/2 Carrier Cohort Study. Cancer Epidemiol Biomarkers Prev 2007, 16(4):740-746.
29. Lecarpentier J., Nogues C., Mouret-Fourme E., Gauthier-Villars M., Lasset C., Fricker J.P., et al. Variation in breast cancer risk associated with factors related to pregnancies according to truncating mutation location, in the French National BRCA1 and BRCA2 mutations carrier cohort (GENEPSO). Breast Cancer Res 2012, 14(4):R99.
30. Kelsey J.L., Horn-Ross P.L. Breast cancer: magnitude of the problem and descriptive epidemiology. Epidemiol Rev 1993, 15(1):7-16.
31. Foulkes W.D., Metcalfe K., Sun P., Hanna W.M., Lynch H.T., Ghadirian P., et al. Estrogen receptor status in BRCA1- and BRCA2-related breast cancer: the influence of age, grade, and histological type. Clin Cancer Res 2004, 10(6):2029-2034.
32. Lakhani S.R., Van De Vijver M.J., Jacquemier J., Anderson T.J., Osin P.P., McGuffog L., et al. The pathology of familial breast cancer: predictive value of immunohistochemical markers estrogen receptor, progesterone receptor, HER-2, and p53 in patients with mutations in BRCA1 and BRCA2. J Clin Oncol 2002, 20(9):2310-2318.
33. Clavel-Chapelon F. Differential effects of reproductive factors on the risk of pre- and postmenopausal breast cancer. Results from a large cohort of French women. Br J Cancer 2002, 86(5):723-727.
34. Ma H., Bernstein L., Pike M.C., Ursin G. Reproductive factors and breast cancer risk according to joint estrogen and progesterone receptor status: a meta-analysis of epidemiological studies. Breast Cancer Res 2006, 8(4):R43.
35. Ando M., Takamoto S., Okita Y., Moroto T. Surgery for three-channeled aortic dissection. Int J Angiol 1998, 7(4):320-324.
36. Russo J., Lynch H., Russo I.H. Mammary gland architecture as a determining factor in the susceptibility of the human breast to cancer. Breast J 2001, 7(5):278-291.
37. Lukanova A., Surcel H.M., Lundin E., Kaasila M., Lakso H.A., Schock H., et al. Circulating estrogens and progesterone during primiparous pregnancies and risk of maternal breast cancer. Int J Cancer 2012, 130(4):910-920.
38. Albrektsen G., Heuch I., Thoresen S., Kvale G. Family history of breast cancer and short-term effects of childbirths on breast cancer risk. Int J Cancer 2006, 119(6):1468-1474.
39. Russo J., Rivera R., Russo I.H. Influence of age and parity on the development of the human breast. Breast Cancer Res Treat 1992, 23(3):211-218.
40. Ringberg A., Palmer B., Linell F. The contralateral breast at reconstructive surgery after breast cancer operation - a histopathological study. Breast Cancer Res Treat 1982, 2(2):151-161.
41. Russo J., Russo I.H. Cellular basis of breast cancer susceptibility. Oncol Res 1999, 11(4):169-178.